Paul Govern

Study explores clinical uses for polygenic risk scores

Vanderbilt University Medical Center has received a five-year, $4.5 million grant from the National Human Genome Research Institute to assess clinical outcomes and economic value of screening large, diverse health care populations for disease risk using polygenic risk scores.

A speedier treatment for depression?

Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder.

Professionalism and patient outcomes

A study of more than 70,000 trauma patients found that those who received care from a service with a high proportion of physicians modeling unprofessional behavior were at a 24% increased risk of death or complications.

Ward honored by National Psoriasis Foundation

Vanderbilt’s Nicole Ward, PhD, was one of three honorees who were the focus of attention at the National Psoriasis Foundation’s 2022 Commit to Cure Gala: Celebrating Women Who Lead, held recently in Chicago.

Sara Horst, MD, MPH

Horst, Patterson receive Physician Builder Awards

Sara Horst, MD, MPH, associate professor of Medicine, and Barron Patterson, MD, associate professor of Pediatrics, have received 2022 Physician Builder Awards.

Epidemic Intelligence Service officers check the humidity and take samples from linens in a patient room while investigating a hospital-associated mucormycosis outbreak in Little Rock, Arkansas, in March 2021.

VUMC to pilot CDC joint training program

Vanderbilt University Medical Center is among 11 centers that will pilot a new federally sponsored training program, the Joint Infectious Diseases/Epidemic Intelligence Service (ID/EIS) Fellowship.

1 11 12 13 14 15 52